Live Breaking News & Updates on பெர்லின் ஸ்டாக் பரிமாற்றம்
Stay updated with breaking news from பெர்லின் ஸ்டாக் பரிமாற்றம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
DGAP-News: J.P. Morgan AG: Stabilisation Notice finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Deutsche Konsum REIT with successful first half of 2020/2021 DGAP-News: Deutsche Konsum REIT-AG / Key word(s): Half Year Results 12.05.2021 / 07:15 Press release - Rental income increased by 32% to EUR 33.0 million - FFO increased by 33% to EUR 20.4 million or EUR 0.58 per share - FFO per share increased by 21% or EUR 0.10 to EUR 0.58 per share - EPRA NAV at EUR 11.17 per share - Net LTV at 55.7% - No significant corona-related rental losses Broderstorf, 12 May 2021 - Deutsche Konsum REIT-AG ( DKR ) (ISIN DE000A14KRD3) closed the first half of the 2020/2021 financial year ( H1 ) with significant growth, as expected. Significant increases in rental income and FFO ....
Search jobs 29-Apr-2021 APONTIS PHARMA AG sets price range for planned IPO between EUR 18.50 and EUR 24.50 per share DGAP-News: APONTIS PHARMA AG / Key word(s): IPO 29.04.2021 / 08:30 The issuer is solely responsible for the content of this announcement. NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THE PRESS RELEASE. APONTIS PHARMA AG sets price range for planned IPO between EUR 18.50 and EUR 24.50 per share ....
SYNLAB sets final offer price for IPO at EUR 18.00 per share Search jobs DGAP-News: Synlab AG / Key word(s): IPO 27.04.2021 / 22:50
Total offer volume of EUR 772 million, assuming full exercise of Greenshoe option Offer price implies a total market capitalisation of EUR 4 billion and a total enterprise value of EUR 5.9 billion Free float expected to amount to 19% of outstanding share capital, if Greenshoe option is fully exercised First day of trading on the Regulated Market (Prime Standard) of the Frankfurt Stock Exchange under the trading symbol SYAB is planned for Friday, 30 April 2021 SYNLAB (the Company ), the largest European clinical laboratory and medical diagnostic services company, has set the final offer price for its initial public offering (the Offering ) at EUR 18.00 per share. Assuming full exercise of the Greenshoe option and based on the final offer price, the total offer volume amounts to EUR 772 million. This compr ....
Disclaimer This release is not for distribution, directly or indirectly, in or into the United States (including its territories and possessions, any State of the United States and the District of Columbia), Australia, Canada or Japan. It does not constitute or form a part of any offer or solicitation to purchase or subscribe for securities in the United States, Australia, Canada or Japan. The shares mentioned herein have not been, and will not be, registered under the US Securities Act of 1933, as amended (the Securities Act ). The shares may not be offered or sold in the United States, except pursuant to an exemption from the registration requirements of the Securities Act. There will be no public offer of shares of SYNLAB AG (the Company ) in the United States. ....